Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2.

Gerhard Regl; Maria Kasper; Harald Schnidar; Thomas Eichberger; Graham W Neill; Michael P Philpott; Harald Esterbauer; Cornelia Hauser-Kronberger; Anna-Maria Frischauf; Fritz Aberger

doi:10.1158/0008-5472.CAN-04-1085

Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2.

Gerhard Regl, Maria Kasper, Harald Schnidar, Thomas Eichberger, Graham W Neill, Michael P Philpott, Harald Esterbauer, Cornelia Hauser-Kronberger, Anna-Maria Frischauf, Fritz Aberger

Institute of Pathology

Research output: Contribution to journal › Original Article › peer-review

200 Citations (Web of Science)

Original language	English
Pages (from-to)	7724-7731
Journal	CANCER RESEARCH
Volume	64
Issue number	21
DOIs	https://doi.org/10.1158/0008-5472.CAN-04-1085
Publication status	Published - 2004

Keywords

BASAL-CELL CARCINOMAS
GENE-EXPRESSION
HUMAN HOMOLOG
CANCER
SKIN
PROTEIN
TUMORS
SEQUENCES
MUTATIONS
PATHWAY

Access to Document

10.1158/0008-5472.CAN-04-1085

Cite this

Regl, G., Kasper, M., Schnidar, H., Eichberger, T., Neill, G. W., Philpott, M. P., Esterbauer, H., Hauser-Kronberger, C., Frischauf, A.-M., & Aberger, F. (2004). Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. CANCER RESEARCH , 64(21), 7724-7731. https://doi.org/10.1158/0008-5472.CAN-04-1085

Regl, Gerhard ; Kasper, Maria ; Schnidar, Harald et al. / Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. In: CANCER RESEARCH 2004 ; Vol. 64, No. 21. pp. 7724-7731.

@article{e029f1ce7bab44d7bd2c03ad0b1865d2,

title = "Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2.",

keywords = "BASAL-CELL CARCINOMAS, GENE-EXPRESSION, HUMAN HOMOLOG, CANCER, SKIN, PROTEIN, TUMORS, SEQUENCES, MUTATIONS, PATHWAY",

author = "Gerhard Regl and Maria Kasper and Harald Schnidar and Thomas Eichberger and Neill, {Graham W} and Philpott, {Michael P} and Harald Esterbauer and Cornelia Hauser-Kronberger and Anna-Maria Frischauf and Fritz Aberger",

year = "2004",

doi = "10.1158/0008-5472.CAN-04-1085",

language = "English",

volume = "64",

pages = "7724--7731",

journal = "CANCER RESEARCH ",

issn = "0008-5472",

publisher = "Amer Assoc Cancer Research",

number = "21",

}

Regl, G, Kasper, M, Schnidar, H, Eichberger, T, Neill, GW, Philpott, MP, Esterbauer, H, Hauser-Kronberger, C, Frischauf, A-M & Aberger, F 2004, 'Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2.', CANCER RESEARCH , vol. 64, no. 21, pp. 7724-7731. https://doi.org/10.1158/0008-5472.CAN-04-1085

Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. / Regl, Gerhard; Kasper, Maria; Schnidar, Harald et al.
In: CANCER RESEARCH , Vol. 64, No. 21, 2004, p. 7724-7731.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2.

AU - Regl, Gerhard

AU - Kasper, Maria

AU - Schnidar, Harald

AU - Eichberger, Thomas

AU - Neill, Graham W

AU - Philpott, Michael P

AU - Esterbauer, Harald

AU - Hauser-Kronberger, Cornelia

AU - Frischauf, Anna-Maria

AU - Aberger, Fritz

PY - 2004

Y1 - 2004

KW - BASAL-CELL CARCINOMAS

KW - GENE-EXPRESSION

KW - HUMAN HOMOLOG

KW - CANCER

KW - SKIN

KW - PROTEIN

KW - TUMORS

KW - SEQUENCES

KW - MUTATIONS

KW - PATHWAY

U2 - 10.1158/0008-5472.CAN-04-1085

DO - 10.1158/0008-5472.CAN-04-1085

M3 - Original Article

C2 - 15520176

SN - 0008-5472

VL - 64

SP - 7724

EP - 7731

JO - CANCER RESEARCH

JF - CANCER RESEARCH

IS - 21

ER -

Regl G, Kasper M, Schnidar H, Eichberger T, Neill GW, Philpott MP et al. Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. CANCER RESEARCH . 2004;64(21):7724-7731. doi: 10.1158/0008-5472.CAN-04-1085